Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medical Genetics

• Publication date

  2005-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jmg.2005.034744PMID 15983021PMCID PMC2564628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients

  2005cited by this paper
• African‐American/White differences in breast carcinoma

  2004cited by this paper
• BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.

  2004cited by this paper
• Breast carcinoma in African‐American and White women

  2004cited by this paper
• Racial differences in genetic factors associated with breast cancer

  2003cited by this paper
• Clinical Outcome and Cosmesis in African‐American Patients Treated with Conservative Surgery and Radiation Therapy

  2003cited by this paper
• Breast cancer genetics in African Americans

  2003cited by this paper
• Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.

  2002cited by this paper
• Molecular and genetic markers in the local-regional management of breast cancer.

  2002cited by this paper
• Hereditary breast cancer.

  2001cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer

  2000cited by this paper
• Racial differences in breast carcinoma survival

  2000cited by this paper
• Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.

  2000cited by this paper
• BRCA1 and BRCA2 and breast cancer incidence: a review.

  1999cited by this paper
• Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

  1999cited by this paper
• How many more breast cancer predisposition genes are there?

  1999cited by this paper
• BRCA1 mutations in African Americans

  1999cited by this paper
• Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

  1999cited by this paper
• Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

  1998cited by this paper
• BRCA-associated breast cancer: absence of a characteristic immunophenotype.

  1998cited by this paper
• BRCA-associated breast cancer in young women.

  1998cited by this paper
• Survival in early-onset BRCA1 breast-cancer patients

  1998cited by this paper
• Inherited breast cancer: increasingly familiar territory.

  1998cited by this paper
• The American Society of Clinical Oncology position on genetic testing: implications for health care providers: workshop no. 4.

  1997cited by this paper
• Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

  1997cited by this paper
• Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area.

  1997cited by this paper
• Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy

  1997cited by this paper
• The American society of clinical oncology position on genetic testing

  1997cited by this paper
• Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

  1997cited by this paper
• The influence of young age on outcome in early stage breast cancer.

  1994cited by this paper
• Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer.

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Age as prognostic factor in premenopausal breast carcinoma.

  1993cited by this paper
• Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group.

  1993cited by this paper
• Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome

  1992cited by this paper
• Hereditary breast cancer.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy.

  1988cited by this paper

• Measuring the accuracy of electronic health record-based phenotyping in the All of Us Research Program to optimize statistical power for genetic association testing.

  2026cites this paper
• Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis

  2025cites this paper
• Investigating the genetic landscape of cancer in Jordan: a step toward personalized care

  2025influential citation
• Reclassification of variants of uncertain significance by race, ethnicity, and ancestry for patients at risk for breast cancer

  2025cites this paper
• PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer

  2024cites this paper
• Disparities in care of older adults of color with cancer: A narrative review

  2024cites this paper
• Gynecologic Care of Black Breast Cancer Survivors

  2024cites this paper
• Universal Genetic Counseling and Testing for Black Women: A Risk-Stratified Approach to Addressing Breast Cancer Disparities.

  2024cites this paper
• Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases.

  2024cites this paper
• In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients

  2024cites this paper
• A Public Health Emergency: Breast Cancer Among Black Communities in the United States.

  2023cites this paper
• Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations

  2023cites this paper
• Words matter: The language of difference in human genetics.

  2022cites this paper
• Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center

  2022cites this paper
• Racial and Ethnic Disparities in Malignant Melanoma: A Literature Review

  2022cites this paper
• Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2‐negative individuals who had genetic testing in a large urban comprehensive cancer center

  2022cites this paper
• Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.

  2021cites this paper
• Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

  2020cites this paper
• A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells

  2020cites this paper
• Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research

  2020cites this paper
• Gene panel screening for insight towards breast cancer susceptibility in different ethnicities

  2020cites this paper
• Assessing the Potential of Chitosan/Polylactide Nanoparticles for Delivery of Therapeutics for Triple-Negative Breast Cancer Treatment

  2019cites this paper
• US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.

  2019cites this paper
• Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities

  2019cites this paper
• Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia

  2019cites this paper
• Exploring Asian Indian and Pakistani views about cancer and participation in cancer genetics research: toward the development of a community genetics intervention

  2017cites this paper
• Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.

  2016cites this paper
• Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer

  2016cites this paper
• Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

  2016cites this paper
• The molecular aetiology of inherited breast cancer in the South African black population

  2016cites this paper
• DualCharacteristics ofNovelHER2KinaseDomain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

  2016cites this paper
• Deleterious BRCA1/2 mutations in an urban population of Black women

  2015cites this paper
• Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

  2015cites this paper
• Living laboratory: whole‐genome sequencing as a learning healthcare enterprise

  2015cites this paper
• What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2

  2015cites this paper
• Clinical Presentation, Prevalence and Management of Breast Cancer in Sokoto, Nigeria

  2014cites this paper
• African American Women’s Limited Knowledge and Experiences with Genetic Counseling for Hereditary Breast Cancer

  2014cites this paper
• Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

  2013cites this paper
• Global ovarian cancer health disparities.

  2013cites this paper
• BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

  2013cites this paper
• Triple-negative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer

  2012cites this paper
• Epidemiology of Breast Cancer in Europe and Africa

  2012influential citation
• Triple-negative breast cancer and PTEN ( phosphatase and tensin homologue ) loss are predictors of BRCA 1 germline mutations in women with early-onset and familial breast cancer , but not in women with isolated late-onset breast cancer

  2012cites this paper
• High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

  2012cites this paper
• Epidemiology and surgical management of breast cancer in gynecological department of Douala General Hospital

  2012cites this paper
• Recruitment of Black Women for a Study of Inherited Breast Cancer Using a Cancer Registry-Based Approach

  2011cites this paper
• The role of BRCA mutation testing in determining breast cancer therapy

  2010cites this paper
• Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.

  2010cites this paper
• Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

  2010cites this paper
• An Examination of Dimensions of Perceived Behavioral Control Regarding Genetic Counseling and Testing for BRCA 1 and BRCA 2 in African-American Women at Moderate to High-Risk for Breast Cancer

  2010cites this paper
• Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned

  2010cites this paper
• How Can We Reach Them? Information Seeking and Preferences for a Cancer Family History Campaign in Underserved Communities

  2009cites this paper
• BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

  2009cites this paper
• Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004

  2009cites this paper
• Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

  2009cites this paper
• Influence of Race/Ethnicity on Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer

  2009cites this paper
• Cancer risk and risk communication in urban, lower-income neighborhoods.

  2009cites this paper
• Recent trends in breast cancer among younger women in the United States.

  2008cites this paper
• Population differences in breast cancer severity.

  2008cites this paper
• Genetic Risk Assessment for Hereditary Ovarian Cancer: BRCA1 and BRCA2

  2008cites this paper
• Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast

  2008cites this paper
• BRCA1/2 in High-Risk African American Women with Breast Cancer: Providing Genetic Testing through Various Recruitment Strategies

  2008influential citation
• Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda

  2008cites this paper
• Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment

  2008cites this paper
• Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

  2007cites this paper
• Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women

  2007cites this paper
• Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006.

  2007cites this paper
• Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study

  2007cites this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cites this paper
• Prevalence of Pathogenic BRCA 1 Mutation Carriers in 5 US Racial / Ethnic Groups

  2007cites this paper
• Outcomes associated with adjuvant hormonal therapy : are there any differences between black and white women with primary breast cancer?

  2007cites this paper
• Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

  2007cites this paper
• Ethnic Disparities in Breast Cancer

  2007cites this paper
• Genetics and the Young Woman with Breast Cancer

  2006cites this paper
• BRCA 1 / 2 SequenceVariantsofUncertainSignificance : APrimer for Providers toAssist inDiscussionsand inMedicalManagement

  year unknowncites this paper